Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $464.74M.
ENTERPRISE VALUE (EV)
$464.74M
Enanta Pharmaceuticals, Inc.
Market Cap
$353.88M
Enterprise Value (EV)
$464.74M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Enanta Pharmaceuticals, Inc. (ENTA) | $353.88M | $464.74M |
| Embecta Corp. (EMBC)vs › | $353.00M | $1.64B |
| Ocugen, Inc. (OCGN)vs › | $352.67M | $340.61M |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | $356.28M |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | $63.83M |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | $399.99M |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | $318.28M |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | $342.57M |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | $307.76M |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | $332.70M |
Market Cap
$353.88M
Total Debt
$143.15M
Cash
$32.30M
Enterprise Value
$464.74M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
